CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 126 filers reported holding CYTOKINETICS INC in Q4 2015. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $360,000 | +2.9% | 44,463 | -8.7% | 0.02% | +57.1% |
Q1 2018 | $350,000 | -11.2% | 48,678 | +50.0% | 0.01% | -39.1% |
Q4 2016 | $394,000 | -25.7% | 32,461 | -56.8% | 0.02% | -4.2% |
Q1 2016 | $530,000 | -40.2% | 75,197 | -11.3% | 0.02% | -42.9% |
Q4 2015 | $886,000 | +226.9% | 84,797 | +109.1% | 0.04% | +320.0% |
Q3 2015 | $271,000 | +38.3% | 40,551 | +39.6% | 0.01% | +42.9% |
Q1 2015 | $196,000 | -9.3% | 29,045 | +7.5% | 0.01% | -12.5% |
Q4 2014 | $216,000 | -65.8% | 27,011 | -85.0% | 0.01% | -72.4% |
Q3 2014 | $632,000 | +21.5% | 179,772 | +65.2% | 0.03% | +7.4% |
Q2 2014 | $520,000 | – | 108,850 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |